Tech
Transfer
Summit

Paris, France
6-7 October 2008

at EuroBiO 2008

About The Tech Transfer Summit

The inaugural Tech Transfer Summit was held in 2007 as part of the European Federation of Biotechnology’s 13th European Congress of Biotechnology. It was founded in partnership between The European Federation of Biotechnology (EFB) and Tech Investor Ltd to meet an increasing need for a better understanding between all the stakeholders in the Biotechnology community on the critical need for efficient transfer of early innovative research to commercializable product technology. The Summit is Europe’s premier think-tank for Technology Transfer professionals, researchers, business angels, Government funding bodies, PE VC professionals, financiers and financial service providers and the legal profession. The Summit provides a networking platform for dissemination and deliberation of problems and solutions alike, available methods and processes and ultimately provides access to business resources that underpin the commercialization of innovative technology. The Summit is of importance to entrepreneurial researchers & innovators, University Tech Transfer Offices, research institutes, corporations, and investors alike, allowing them to successfully network, collaborate and form partnerships that can help drive forward innovative technologies to the commercial markets.

Vision

The creation of a network of technology transfer professionals, leading researchers and corporate biotechnology stakeholders to help commercialize the ever increasing amount of innovative biotechnology in our society.

Mission

The constructive deliberation and debate that the Summit provides, coupled with exclusive networking opportunities with key biotechnology stakeholders, will enable the process of technology transfer to become better understood and applied and subsequently deliver that which we all strive to achieve; the commercialization of biotechnological innovation.

Goals

EFB - The Voice of Science The European Federation of Biotechnology is the Voice of Science for the biotechnology community in Europe.  Europe’s largest and most inclusive biotechnology organization with over 235 Institutional and 6,000 personal members from around the world, the EFB was founded by leading European scientific and learned societies in 1978 to serve as the biotechnology community.

The aims of the EFB are to foster a positive environment for biotechnology and to enable biotechnology to serve its rightful role in society, by promoting research and innovation at the cutting edge of biotechnology and the beneficial application and utilization of science. EFB provides a forum for interdisciplinary and international cooperation between stakeholders from public research and industry, and works to improve scientific education and to facilitate an informed dialogue between scientists and the public.

Application for membership is open to Public and Private Companies, National Biotechnology Associations, Learned and Scientific Societies, Universities, Research Institutes, Scientific Foundations, Bio Regions, Science Parkers, and individuals active in the biotechnology sector. EFB keeps close contact with the national biotech communities and with the European Institutions.

About Tech Investor Tech Investor Ltd (http://www.tech-investor.com) operates within the Life Science, Biotechnology and Chemical Industry sectors. Consulting on business development and strategy, Tech Investor also organizes exclusive select business-focused events in partnership with organisations that provide stakeholders with unsurpassed access to business leaders, original relevant information, and expertise and knowledge in all aspects of the commercialization of technological innovation.  Tech Investor recognizes the increasingly multi-disciplinary nature of technology and the diverse interactions in both science and business, that are providing new innovation and investment opportunities at an unprecedented rate.  Tech Investor recognizes the importance of “the business of science” and the critical role this plays in successful commercialization.

Download the Programme (PDF) here